The evolution of views on the erythroderma

Abstract

Erythroderma is inflammation ofpart or all of the skin. The diagnosis of an erythroderma puts the doctor in very difficult situation as he should solve a problem with many unknowns. The commonly accepted classification of an erythroderma doesn’t exist, and classification by Louis An Jeanne Brock based on separation of erythroderma on primary and secondary, is seldom used in recent years. At the end of the XX century most of authors refused division of erythroderma on primary and secondary. It is considered that “primary” erythroderma is a toxiderma and chronically proceeding malignant lymphoma of skin. Eryhtroderma represent one of the most complex problems of dermatology. First of all, it is explained by variety of the reasons, a pathogenesis ambiguity, and rather monotonous clinical picture, tendency of many forms of an erythroderma to a long and heavy current and resistance to therapy. Molecular immunology, immunophenotyping and genotyping methods help to differentiate various forms of the disease. Evolution of views of erythroderma with the detailed description of historical aspects, modern views and convenient classification are presented.

Keywords

erythroderma / classification / historical aspects / modern views

References

[1] Заславский Д.В., Раводин Р.А., Татарская О.Б., Сыдиков А.А., Хведелидзе М.Г. Эритродермия: современные вопросы диагностики и лечения. Педиатр. 2014; 1: 97-102.

[2] Brocq L. Precis-atlas de practique dermatolgigue. Paris; 1921: 792-818.

[3] Дарье Ж. Основы дерматологии. Пер. с франц. М.-Л.: Госиздат; 1930: 57-67.

[4] Herberg J. Erythrodermien. In: H. Von Gottron, W. Schonfeld, eds. Dermatologie and Venerologie. Stutgart; 1953: 11-1.

[5] Nicolis G., Helwig E.B. Exfoliation dermatitis. A clinic-pathological study of 135 cases. Arch. Dermatolog., 1973; 108(3): 788-97.

[6] Молочков А.В., Ковригина А.М., Меньщикова Г.В., Федоровская А.В. К дифференциальной диагностике вторичных эритродермий. Российский журнал кожных и венерических болезней. 2011; 14(6): 41-3.

[7] Braegelmann J., D Erme A.M., Akmal S., Maier J., Braegelmann C., Wenzel J. Interleukin-36 (IL-1F9) identifies psoriasis among patients with erythroderma. Acta. Dermatol. Venereol. 2016; 96(3): 386-7. doi: 10.2340/00015555-2265.

[8] Ralfkiaer E., Lange Wantzin G., Mason D.Y., Hou-Jensen K., Stein H., Thomsen K. Phenotypic characterization of lymphocyte subsets in mycosis fungoides: comparison with large plaque parapsoriasi and benign chronic dermatoses. Am. J. Clin. Pathol. 1985; 84(5): 610-9.

[9] Willemze R., de Graaff-Reitsma C.B., Cnossen J., van Vloten W.A., Meijer C.J. Characterization of T-cell subpopulation in skin and peripheral blood of patients with cutaneous T-cell lymphomas and benign inflammatory dermatoses. J. Invest. Dermatol. 1983; 80(1): 60-6.

[10] Willemze R., Jaffe E.S., Burg G., Cerroni L., Berti E., Swerdlow S.H., Ralfkiaer E. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005; 105: 3768-85.

[11] Tosca A.D., Varelzidis A.G., Economidou J., Stratigos J.D. Mycosis fungoides: evaluation of immunohistochemical criteria for the early diagnosis of the disease and differentiation between stages. J. Am. Acad. Dermatol. 1986; 15(2): 237-45.

[12] Introcaso C.E., Hess S.D., Kamoun M., Ubriani R., Gelfand J.M., Rook A.H. Association of change in clinical status and change in the percentage of the CD4+ CD26- lymphocyte population in patients with Sezary syndrome. J. Am. Acad. Dermatol. 2005; 53(3): 428-34.

[13] Kelemen K., Guitart J., Kuzel T.M., Goolsby C.L., Peterson L.C. The usefulnessof CD26 in flow cytometric analysis of peripeheral blood in Sezary syndrome. Am. J. Clin. Pathol.; 2008; 129(1): 146-56.

[14] Sokolowska Wojdylo M., Wenzel J., Gaffal E., Wenzel J., Lenz J., Speuser P., Erdmann S. Circulating clonal CLA+ and CD4+ T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7. Br. J. Dermatol. 2005; 152(2): 258-64.

[15] Fierro M.T., Novelli M., Quaglino P., Comessatti A., Fava P., Ortoncelli M., et al. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythrodermas. Dermatology. 2008; 216(3): 213-21.

[16] Ortonne N., Huet D., Gaudez C., Marie-Cardine A, Schiavon V, Bagot M., et al. Significance of circulating T-cell clones in Sezary syndrome. Blood. 2006; 107(10): 4030-8.

[17] Klemke C.D., Fritzischng B., Franz B., Kleinmann E.V., Oberle N., Poenitz N., Sykora J. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sezary syndrome from other cutaneous T-cell lymphomas. Leukemia. 2006; 20(6): 1123-9.

[18] Burg G., Kempf W., Cozzio A., Feit J., Willemze R., Jaffe E., et al. WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J. Cutan. Pathol. 2005; 32(10): 647-74.

[19] Walsh N.M., Prokopetz R., Tron V.A.. Sawyer D.M., Watters A.K., Murray S., Zip C. Histopathology in erythroderma: review of a series of cases by multiple observers. J. Cutan. Pathol. 1994; 21(5): 419-23.

[20] Worm A.M., Taaning E., Rossing N., Parving H.H., Clemmensen O.J. Distribution and degradation of albumin in extensive skin disease. Br. J. Dermatol. 1981; 104(4): 389-96.

[21] Олисова О.Ю., Потекаев Н.С. Псевдолимфомы кожи. М.: Практика; 2013.

[22] Thestrup-Pedersen K., Halkier-Sorensen L., Sogaard H., Zachariae H. The red man syndrome: exfoliative dermatitis of unknown etiology: a description and follow-up study of 38 patients. J. Am. Acad. Dermatol. 1988; 18(6): 1307-12.

[23] Sigurdsson V., Steegmans P.H., van Vloten W.A. The incidence of erythroderma: a survey among all dermatologists in the Netherlands. J. Am. Acad. Dermatol. 2001; 45(5): 675-8.

[24] Nishijima S. Papuloerythroderma associated with hepatocellular carcinoma. Br. J. Dermatol. 1998; 139(6): 1115-6.

[25] Sigurdsson V., Toonstra J., Hezemans-Boer M., van Vloten W.A. . Erythroderma: a clinical and follow-up studt of 102 patients, with special emphasis on survival. J. Am. Acad. Dermatol. 1996; 35(1): 53-7.

[26] Thami G.P., Sharma N.L., Sharma A., Sharma R.C. Exfoliative dermatitis and malignant melanoma: coincidence or association. Int. J. Dermatol. 1996; 35(9): 682.

[27] Antony F., Ardern-Jones M., Evans A.V., Rosenbaum T., Russell-Jones R. Giant condyloma of Buschke-Lowenstein in association with erythrodema. Clin. Exp. Dermatol. 2003; 28(1): 46-9.

[28] Marsch W.Ch., Stuttgen G. Generalized Hailey-Hailey disease. Br. J. Dermatol. 1978; 99(2): 553-60.

[29] Ban M., Ichihashi N., Kitajima Y. Cutaneous plasmacytic pseudolymphoma with erythroderma. Int. J. Dermatol.; 1998; 37(10): 778-80.

[30] Feind-Koopmans A.G., Lucker G.P., van de Kerkgof P.C. Acquired ichthyosiform erythrodema and sarocidosis. J. Am. Acad. Dermatol. 1996; 35(5, Pt 2): 826-8.

[31] Morrison J.G. Sarcoidosis in a child, presenting as an erythrodema with keratotic spines and palmar pits. Br. J. Dermatol. 1976; 95(1): 93-7.

[32] De Spain J., Clark D.P. Subacute cutaneous lupus erythematodus presenting as erythroderma. J. Am. Acad. Dermatol. 1988; 19(2): 388-92.

[33] Horn T.D., Alomonte V., Vogesang G., Kennedy J.M. Erythroderma after autologous bone marrow transplantation modified by administration of cyclosporine and interferon gamma for breast cancer. J. Am. Acad. Dermatol. 1996; 35(3): 826-8.

[34] Patrizi A., Pileri S., Rivano M.T., Di Lernia V. Malignant histiocytosis presenting as erythroderma. Int. J. Dermatol.; 1990; 29(3): 214-6.

[35] Schrivener Y., Jeandidier N, Asch P.H., Le Coz C.J., Grosshans E., Cribier B. Erythrodema induced by hypercalcitoninemia: two cases. Ann. Dermatol. Venereol. 2002; 129(2): 221-4.

[36] Chan Y.C., Yosipovith G. Erythroderma: an unusual presentation of pulmonary tuberculosis. Br. J. Dermatol. 2003; 148(10): 346-8.

[37] King Jr. L.E., Dufresne Jr. R.G., Lovett G.L., Rosin M.A. Erythroderma: review of 82 cases. South. Med. J. 1986; 79(10): 1210-5.

[38] Arita K., Akiyama M., Sakai T., Shimizu H. Severely heperkeratotic erythroderma associated with Hodgkin’s disease: does a high serum level of granulocyte-colony stimulating factor contribute to formation of skin lesions. J. Am. Acad. Dermatol. 2003; 49(4): 772-3.

[39] Leong A.S., Cowled P.A., Zalewski P.D., Burry J.N., Meredith D.J., Forbes I.J. Erythroderma, an unusual manifestation of B-cell lymphoma. Br. J. Dermatol. 1978; 99(1) 99-106.

[40] De Connick A., De Hou M.F., Peters O., Van Camp B., Roseeuw D.I. Aleukemic leukemia cutis: an usual presentation of adult myelomonocytic leukemia. Dermatologica. 1986; 172(5): 272-5.

[41] Hashizume H., Nakayama F., Oku T., Takigawa M. Adult T-cell leukemia with regression of erythroderma and simultaneous emergence of leukemia. J. Acad. Dermatol. 1992; 27(5, Pt 2): 846-9.

[42] Granjo E., Lima M., Lopes J.M., Doria S., Orfao A., Ying S., et al. Chronic eosinophilic leukemia presenting with erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and theraputic approach: a case report. Acta Haematol. 2002; 107(2): 108-12.

[43] Denton K., Wilson C.L., Venning V.A. Primamry cutaneous anaplastic large-cell lymphoma with a prolonged erythrodemic prodrome. Br. J. Dermatol. 1992; 126(3): 297-300.

RIGHTS & PERMISSIONS

Eco-Vector